213
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series

, , , , , & show all
Pages 424-427 | Received 22 Aug 2017, Accepted 16 Nov 2017, Published online: 29 Nov 2017

References

  • Friedman JM, Riccardi VM. Neurofibromatosis: phenotype, natural history and pathogenesis. 3rd. Baltimore, MD: John Hopkins University Press;1999.
  • Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, Hoving EW, Meijer L, den Dunnen WF, de Bont ES. Neurofibromatosis type 1 associated low grade gliomas: a comparison with sporadic low grade gliomas. Crit Rev Oncol Hematol. 2016 Aug;104:30–41.
  • Gayre GS, Scott IU, Feuer W, Saunders TG, Siatkowski RM. Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol. 2001;21:1–7.
  • Lund AM, Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr. 1991;150:835–38.
  • Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61:189–98.
  • Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol. 1997;41:143–49.
  • Avery RA, Hwang EI, Ishikawa H, Acosta MT, Hutcheson KA, Santos D, Zand DJ, Kilburn LB, Rosenbaum KN, Rood BR, et al. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol. 2014;132:265–71.
  • Topcu-Yilmaz P, Kasim B, Kiratli H. Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1. Jpn J Ophthalmol. 2014;58:172–76.
  • Keller J, Sanchez-Dalmau BF, Villoslada P. Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion loss. PLoS One. 2014;9(5):e97444.
  • Rebolleda G, De Dompablo E, Munoz-Negrete J. Ganglion cell layer analysis unmasks axonal loss in anterior optic neuritis. J Neurophthalmol. 2015;35:165–67.
  • NIH Consensus Development Conference. Neurofibromatosis. Conference statement. Arch Neurol. 1988;45:575–78.
  • Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol. 2011;31:269–78.
  • Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol. 2012;14:790–97.
  • Banc A, Stan C, Florian IS. Optical coherence tomography as a marker of vision in children with optic pathway gliomas. Childs Nerv Syst. 2017 Aug 26. 10.1007/s00381-017-3578-8 [Epub ahead of print Review]
  • Avery RA, Cnaan A, Schuman JS, Chen CL, Glaug NC, Packer RJ, Quinn GE, Ishikawa H. Intra- and inter-visit reproducibility of ganglion cell-inner plexiform layer measurements using handheld optical coherence tomography in children with optic pathway gliomas. Am J Ophthalmol. 2014;158:916–23.
  • Avery RA, Cnaan A, Schuman JS, Trimboli-Heidler C, Chen CL, Packer RJ, Ishikawa H. Longitudinal change of circumpapillary retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2015;160:944–52.
  • Avery RA, Cnaan A, Schuman JS, Chen CL, Glaug NC, Packer RJ, Quinn GE, Ishikawa H. Reproducibility of circumpapillary retinal nerve fiber layer measurements using handheld optical coherence tomography in sedated children. Am J Ophthalmol. 2014;158:780–87.
  • Bear MF, Connors BW, Paradiso MA. 2007. Neuroscience: exploring the brain. Baltimore, MD:Lippincort.
  • Feng L, Zhao Y, Yoshida M, Chen H, Yang JF, Kim TS, Cang J, Troy JB, Liu X. Sustained ocular hypertension induces dendritic degeneration of mause retinal ganglion cells that depends on cell type and location. Invest Ophthalmol Vis Sci. 2013;54(2):1106–17.
  • Gabilondo I, Sepúlveda M, Ortiz-Perez S, Fraga-Pumar E, Martínez-Lapiscina EH, Llufriu S, Solá N, Saiz A, Sanchez-Dalmau B, Villoslada P. Retrograde retinal damage after acute optic tract lesion in MS. J Neurol Neurosurg Psychiatry. 2013;84:824–26.
  • Jacob M, Raverot G, Jouanneau E, Borson-Chazot F, Perrin G, Rabilloud M, Tilikete C, Bernard M, Vighetto A. Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography. Am J Ophthalmol. 2009;147:64–70.
  • Ohkubo S1, Higashide T, Takeda H, Murotani E, Hayashi Y, Sugiyama K. Relationship between macular ganglion cell complex parameters and visual field parameters after tumour resection in chiasmal compression. Jpn J Ophthalmol. 2012;56:68–75.
  • Keller J, Sanchez-Dalmau BF, Villoslada P. Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion cells. Plos One. 2014;9:e97444.
  • Gürağaç FB, Totan Y, Güler E, Tenlik A, Ig E. Normative spectral domain optical coherence tomography data in healthy Turkish children. Semin Ophthalmol. 2017;32:216–22.
  • Al-Haddad C, Barikian A, Jaroudi M, Massoud V, Tamim H, Noureddin B. Spectral domain optical coherence tomography in children: normative data and biometric correlations. BMC Ophthalmol. 2014;2014(14):53.
  • Pawar N, Maheshwari D, Ravindran M, Ramakrishnan R. Retinal nerve fiber layer thickness in normal Indian pediatric population measured with optical coherence tomography. Indian J Ophthalmol. 2014;62:412–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.